{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1043"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"107"}],"units":"Participants"}],"description":"The change in baseline for AdvSM-SAF TSS was correlated with the change in baseline for serum tryptase. Spearman correlation coefficients were performed with corresponding scatter plots on change from baseline.","groups":[{"description":"Avapritinib was administered once daily as an immediate-release tablet, orally, in 28-day cycles.","id":"OG000","title":"Avapritinib"}],"paramType":"NUMBER","populationDescription":"Safety Population: all participants who received ≥1 dose of avapritinib.","reportingStatus":"POSTED","timeFrame":"Baseline, Month 10","title":"Correlation Between TSS and Serum Tryptase","type":"SECONDARY","unitOfMeasure":"Spearman Coefficient"}